MedPath

Portable Ultrasound to Predict Heart Failure Readmission Risk

Not Applicable
Withdrawn
Conditions
Heart Failure
Patient Readmission
Interventions
Diagnostic Test: Ultrasound
Registration Number
NCT05980533
Lead Sponsor
The Guthrie Clinic
Brief Summary

The purpose of this research is to use a handheld ultrasound to assess patients with congestive heart failure (CHF) to see if the ultrasound can help predict readmission to the hospital. The study will include patients who are admitted to the hospital for CHF. Participants will have two ultrasounds at hospital discharge and at a follow up visit.

Detailed Description

The purpose of this research is to see if a portable ultrasound can help predict readmission to the hospital for patients who are admitted to the hospital for CHF. The study will enroll patients who take part in Mobile Integrated Healthcare as part of their routine care. Participants will have two ultrasounds. The first ultrasound will be at hospital discharge.

Between seven to ten days after hospital discharge participants will be visited at their home in follow-up as the usual standard of care for Mobile Integrated Healthcare. At this visit participants will have a second ultrasound. Participants will be followed for one year for hospital readmission.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Primary admission diagnosis is listed as congestive heart failure, with an acute component of decompensation.
  • Age greater than 18 years.
  • Principal residence within the geographic reach of our MIH program.
Exclusion Criteria
  • pregnant women

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
UltrasoundUltrasoundUltrasound at hospital discharge and at follow up in 7-10 days
Primary Outcome Measures
NameTimeMethod
Hospital Readmission30 days

Hospital readmission within 30 days of discharge

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath